Clinical Trial Update: A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy of SIBP04 in subjects with non-squamous non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SIBP04 (SIBP04)

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: Non-squamous Non-small-cell Lung Cancer | Phase 3 | Status: COMPLETED